Optiver Holding
INO icon

Optiver Holding’s Inovio Pharmaceuticals INO Stock Holding History

Optiver Holding’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Buy
+1,325
New +$1.57K ﹤0.01% 2398
2025
Q4 		– Sell
-24
Closed -$56 – 2709
2025
Q3 		$56 Buy
+24
New +$46 ﹤0.01% 2615

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Optiver Holding's INO Position: Q2 2026 in Review

Optiver Holding opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 1,325 shares worth $1.46K. The stake represents ﹤0.01% of the portfolio and ranks #2398 among its holdings. This is a return to the name: Optiver Holding previously reported a position in INO as recently as Q3 2025.

Optiver Holding first reported a position in INO in Q3 2025 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Optiver Holding held 1,325 shares of Inovio Pharmaceuticals worth $1.46K as of Q2 2026.
  • Inovio Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2398 holding.
  • Optiver Holding first reported a position in Inovio Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.